Evinco Therapeutics combines deep expertise in stem cells, NK cell immunology, extracellular vesicle (EV) biology, and translational neuroscience to develop first-in-class therapies for neuroinflammatory disease.
Advanced NK Cell & EV Platform
Our proprietary platform leverages scalable induced NK (iNK) cell manufacturing to produce highly characterised extracellular vesicles with immune-modulating activity. We have developed robust purification, characterisation, and GMP-aligned processes to support clinical translation.
This creates a reproducible, scalable biologic modality with strong IP and platform expansion potential.
Targeting Neuroinflammation in Alzheimer’s Disease
Neuroinflammation is a key driver of Alzheimer’s progression. Our NK-derived EVs are designed to modulate inflammatory pathways within the brain and are delivered intranasally – a non-invasive approach intended to directly access the central nervous system and overcome limitations of conventional biologics.
Preclinical data support therapeutic potential, positioning the program for proof-of-concept and value inflection.
Experienced Translational Leadership
Our team brings decades of experience advancing cell therapies from discovery through IND-enabling studies and into early clinical development..
